These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12057621)

  • 21. [Persistence of immunity to attenuated measles live vaccine. VI. Observation on the results of revaccination with different vaccines via varied routes].
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):541-5. PubMed ID: 6418355
    [No Abstract]   [Full Text] [Related]  

  • 22. Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration.
    Kok PW; Kenya PR; Ensering H
    Trans R Soc Trop Med Hyg; 1983; 77(2):171-6. PubMed ID: 6868097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.
    Hirose M; Hidaka Y; Miyazaki C; Ueda K; Yoshikawa H
    Scand J Infect Dis; 1997; 29(2):187-90. PubMed ID: 9181657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.
    Reisinger EC; Tschismarov R; Beubler E; Wiedermann U; Firbas C; Loebermann M; Pfeiffer A; Muellner M; Tauber E; Ramsauer K
    Lancet; 2019 Dec; 392(10165):2718-2727. PubMed ID: 30409443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka.
    Wijesinghe PR; Abeysinghe MR; Yoksan S; Yao Y; Zhou B; Zhang L; Yaich M; Neuzil KM; Victor JC
    Vaccine; 2014 Aug; 32(37):4751-7. PubMed ID: 24951871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The assessment of the immunogenicity of different batches of live L-16 measles vaccine in urban and rural localities].
    Ninashvili NZ; Gelikman BG; Shavdiia NT; Elikashvili MIu; Gogokhia TsN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):72-4. PubMed ID: 8079578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative testing of live measles vaccines manufactured in France, Japan, and Russia].
    Popov VF; Iunasova TN; Povalikhina LV; Shitikova OIu
    Vopr Virusol; 1995; 40(6):253-7. PubMed ID: 8686260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?
    Michel R; Berger F; Ravelonarivo J; Dussart P; Dia M; Nacher M; Rogier S; Moua D; Sarr FD; Diop OM; Sall AA; Baril L
    Vaccine; 2015 May; 33(20):2301-6. PubMed ID: 25843268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects of single-component measles vaccine in school children.
    Tosun S; Olut AI; Tansug N
    Vaccine; 2017 Dec; 35(52):7309-7311. PubMed ID: 29128384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
    Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
    J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.